ALDH3A1 and hepatocellular carcinoma: Another oncological application of modulation of HNE metabolism was suggested in relation to the inhibition of cytosolic class 3 aldehyde dehydrogenase (ALDH3) by antisense oligonucleotides in hepatoma cells [59].